Topic

Chris Spivey is the editorial director of 

Articles

Change of roster does not change the goal line. We are all patients first.

New Beginnings

The mission continues. Let science be the guide.

The Next Chapter

Vaccines define the path to putting pandemic restrictions and pain in the rear-view mirror.

Avoiding Delays on the Road to Normalcy

Bio/pharmaceutical manufacturers have made a good first step toward global vaccination through pledging doses at no- to low-profit rates. 

A “We are the World” Vaccination Effort?

Mike Hennessy, Sr., is the founder and chairman of MJH Life Sciences.

Innovation drives the development of emerging drug modalities. 

From the Chairman: Technology Advances Foster New Therapies

As face masks start to come off, bio/pharma’s COVID-19 battle goes on.

Moving Into the Next Phase

Smart, accurate, science-based messaging is needed to advance bio/pharma science.

Avoiding Unforced Errors in the Bio/Pharma Industry

Bio/pharma works hard today to change the calendar to tomorrow.

Fighting Through This Slow Season of Change

Viewpoint: Mike Hennessy, Sr., founder and chairman of MJH Life Sciences, commends the leadership of the pharmaceutical industry in combatting the COVID-19 pandemic.

How Pharmaceutical Innovation is Saving the World

A complicated vaccination rollout and mixed messages may derail the pandemic endgame

Viewpoints